178 related articles for article (PubMed ID: 28504694)
1. The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells.
Koushyar S; Economides G; Zaat S; Jiang W; Bevan CL; Dart DA
Oncogenesis; 2017 May; 6(5):e333. PubMed ID: 28504694
[TBL] [Abstract][Full Text] [Related]
2. Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells.
Koushyar S; Uysal-Onganer P; Jiang WG; Dart DA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373067
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.
Gamble SC; Chotai D; Odontiadis M; Dart DA; Brooke GN; Powell SM; Reebye V; Varela-Carver A; Kawano Y; Waxman J; Bevan CL
Oncogene; 2007 Mar; 26(12):1757-68. PubMed ID: 16964284
[TBL] [Abstract][Full Text] [Related]
4. Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.
Dart DA; Spencer-Dene B; Gamble SC; Waxman J; Bevan CL
Endocr Relat Cancer; 2009 Dec; 16(4):1157-69. PubMed ID: 19635783
[TBL] [Abstract][Full Text] [Related]
5. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.
Dart DA; Brooke GN; Sita-Lumsden A; Waxman J; Bevan CL
Oncogene; 2012 Oct; 31(43):4588-98. PubMed ID: 22179832
[TBL] [Abstract][Full Text] [Related]
6. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
[TBL] [Abstract][Full Text] [Related]
7. Prohibitin promotes androgen receptor activation in ER-positive breast cancer.
Liu P; Xu Y; Zhang W; Li Y; Tang L; Chen W; Xu J; Sun Q; Guan X
Cell Cycle; 2017 Apr; 16(8):776-784. PubMed ID: 28272969
[TBL] [Abstract][Full Text] [Related]
8. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
Dai Y; Ngo D; Jacob J; Forman LW; Faller DV
Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
[TBL] [Abstract][Full Text] [Related]
9. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
10. Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway.
Roediger J; Hessenkemper W; Bartsch S; Manvelyan M; Huettner SS; Liehr T; Esmaeili M; Foller S; Petersen I; Grimm MO; Baniahmad A
Mol Cancer; 2014 Sep; 13():214. PubMed ID: 25216853
[TBL] [Abstract][Full Text] [Related]
11. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
[TBL] [Abstract][Full Text] [Related]
12. PMA induces androgen receptor downregulation and cellular apoptosis in prostate cancer cells.
Itsumi M; Shiota M; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Inokuchi J; Tatsugami K; Uchiumi T; Naito S
J Mol Endocrinol; 2014 Aug; 53(1):31-41. PubMed ID: 24780839
[TBL] [Abstract][Full Text] [Related]
13. Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5 - a calcitriol analog.
Mooso B; Madhav A; Johnson S; Roy M; Moore ME; Moy C; Loredo GA; Mehta RG; Vaughan AT; Ghosh PM
Genes Cancer; 2010 Nov; 1(9):927-940. PubMed ID: 21552398
[TBL] [Abstract][Full Text] [Related]
14. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
[TBL] [Abstract][Full Text] [Related]
15. Antisense MDM2 enhances E2F1-induced apoptosis and the combination sensitizes androgen-sensitive [corrected] and androgen-insensitive [corrected] prostate cancer cells to radiation.
Udayakumar TS; Hachem P; Ahmed MM; Agrawal S; Pollack A
Mol Cancer Res; 2008 Nov; 6(11):1742-54. PubMed ID: 19010821
[TBL] [Abstract][Full Text] [Related]
16. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.
Lin HP; Lin CY; Hsiao PH; Wang HD; Jiang SS; Hsu JM; Jim WT; Chen M; Kung HJ; Chuu CP
PLoS One; 2013; 8(12):e82625. PubMed ID: 24349321
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor.
Rajamahanty S; Alonzo C; Aynehchi S; Choudhury M; Konno S
J Biomed Sci; 2010 Jan; 17(1):5. PubMed ID: 20102617
[TBL] [Abstract][Full Text] [Related]
18. Repression of androgen receptor transcription through the E2F1/DNMT1 axis.
Valdez CD; Davis JN; Odeh HM; Layfield TL; Cousineau CS; Berton TR; Johnson DG; Wojno KJ; Day ML
PLoS One; 2011; 6(9):e25187. PubMed ID: 21966451
[TBL] [Abstract][Full Text] [Related]
19. Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor.
Hong MY; Seeram NP; Heber D
J Nutr Biochem; 2008 Dec; 19(12):848-55. PubMed ID: 18479901
[TBL] [Abstract][Full Text] [Related]
20. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]